Healthtech Investors & VC Firms

3445 firms in this list, with a median first check of $500K. 746 of them lead rounds. Generated from verified public data and updated continuously.

Fund	FoxScore	HQ	Invests	Stage	Check	CRM
MO Montis Capital ŁDTPTPLD6 people	88🔒	Warsaw	PL	Series A–Growth	$1.6M – $5.5M	+ Add to CRM
NE Nest.Bio Ventures DTJLLDSC12 people	88🔒	Somerville	US	—	—	+ Add to CRM
OQ Oquirrh Ventures JSJYJKRH6 people	88🔒	Salt Lake City	US	Growth–Late Stage	$10M – $50M	+ Add to CRM
PO Positive Ventures FKMMASBC12 people	88🔒	São Paulo	BR	Pre-Seed–Series A	—	+ Add to CRM
UN Underdog Labs ACDHHLUS6 people · Leads rounds	88🔒	San Francisco	US	Pre-Seed–Seed	$5K – $1M	+ Add to CRM
ZO Zoic Capital NNDABIE12 people	88🔒	Seattle	US	Seed–Series A	—	+ Add to CRM
CA Catalyst Romania MGASAGJK5 people	88🔒	Bucharest	RO	Seed–Growth	$1.2M – $3.6M	+ Add to CRM
IN InterValley Ventures JHSWYKJP8 people	88🔒	Melbourne	AU	Seed–Series A	—	+ Add to CRM
NA Narya Capital CGFDWSJV5 people · Follows rounds	88🔒	Columbus	US	Pre-Seed–Late Stage	—	+ Add to CRM
NA naturalX Health Ventures MACPSBYC5 people · Leads rounds	88🔒	Karlsruhe	DE	Seed–Late Stage	$3.2M – $5.4M	+ Add to CRM
SP Spring Impact Capital KIGDHAOH11 people	88🔒	Vancouver	CA	Pre-Seed–Series A	—	+ Add to CRM
WA WakeUp Capital FWMPAPMW8 people	88🔒	Dublin	IE	Pre-Seed–Series A	—	+ Add to CRM
20 20/20 HealthCare Partners LLC HBDZHNRV7 people · Leads rounds	88🔒	Auburndale	US	Seed–Late Stage	—	+ Add to CRM
AC Accelia Capital ACCBJRCP7 people	88🔒	Montreal	CA	Seed–Series A	$219K – $730K	+ Add to CRM
AR Artiman Ventures ASBWRRTD10 people	88🔒	Palo Alto	US	Seed–Late Stage	$2M – $6M	+ Add to CRM
FI FINCA Ventures WMABMTJK4 people	88🔒	Washington DC	US	Pre-Seed–Series A	—	+ Add to CRM
HA Happiness Capital DLDHMCTG7 people	88🔒	Hong Kong	HK	Seed–Growth	—	+ Add to CRM
QU Qubit Health Capital JNPRGKMH10 people	88🔒	London	GB	—	—	+ Add to CRM
TR Truffle Capital BRHMMMAM7 people · Leads rounds	88🔒	Paris	FR	Seed–Growth	$5M – $15M	+ Add to CRM
WI Wildwood Ventures JMAMNTAR7 people · Follows rounds	88🔒	Boulder	US	Pre-Seed–Series A	—	+ Add to CRM
WX WXR Fund AAMPALMW4 people · Follows rounds	88🔒	San Francisco	US	Pre-Seed–Series A	$100K – $1M	+ Add to CRM
AN Anthropy Partners BPBFCBGF6 people	88🔒	Seattle	US	Pre-Seed–Series A	—	+ Add to CRM
CL Clal Biotechnology Industries AALNNMTB9 people	88🔒	Tel Aviv	IL	Seed–Late Stage	—	+ Add to CRM
DB DBH Investment Zrt. DFDJLÜMJ9 people	88🔒	Budapest	HU	Seed–Series B	$216K – $1.6M	+ Add to CRM

Montis Capital

WarsawSeries A–Growth$1.6M – $5.5M

ŁDTPTPLD6 people

Nest.Bio Ventures

Somerville

DTJLLDSC12 people

Oquirrh Ventures

Salt Lake CityGrowth–Late Stage$10M – $50M

JSJYJKRH6 people

Positive Ventures

São PauloPre-Seed–Series A

FKMMASBC12 people

Underdog Labs

San FranciscoPre-Seed–Seed$5K – $1M

ACDHHLUS6 people

Zoic Capital

SeattleSeed–Series A

NNDABIE12 people

Catalyst Romania

BucharestSeed–Growth$1.2M – $3.6M

MGASAGJK5 people

InterValley Ventures

MelbourneSeed–Series A

JHSWYKJP8 people

Narya Capital

ColumbusPre-Seed–Late Stage

CGFDWSJV5 people

naturalX Health Ventures

KarlsruheSeed–Late Stage$3.2M – $5.4M

MACPSBYC5 people

Spring Impact Capital

VancouverPre-Seed–Series A

KIGDHAOH11 people

WakeUp Capital

DublinPre-Seed–Series A

FWMPAPMW8 people

20/20 HealthCare Partners LLC

AuburndaleSeed–Late Stage

HBDZHNRV7 people

Accelia Capital

MontrealSeed–Series A$219K – $730K

ACCBJRCP7 people

Artiman Ventures

Palo AltoSeed–Late Stage$2M – $6M

ASBWRRTD10 people

FINCA Ventures

Washington DCPre-Seed–Series A

WMABMTJK4 people

Happiness Capital

Hong KongSeed–Growth

DLDHMCTG7 people

Qubit Health Capital

London

JNPRGKMH10 people

Truffle Capital

ParisSeed–Growth$5M – $15M

BRHMMMAM7 people

Wildwood Ventures

BoulderPre-Seed–Series A

JMAMNTAR7 people

WXR Fund

San FranciscoPre-Seed–Series A$100K – $1M

AAMPALMW4 people

Anthropy Partners

SeattlePre-Seed–Series A

BPBFCBGF6 people

Clal Biotechnology Industries

Tel AvivSeed–Late Stage

AALNNMTB9 people

DBH Investment Zrt.

BudapestSeed–Series B$216K – $1.6M

DFDJLÜMJ9 people

Data sourced from public filings and firms' own websites — see our methodology.